Tissue engineering entails the in vitro development of bioartificial tissues as well as the in vivo manipulation of cell growth and function using cells isolated from donor tissue and biocompatible scaffold materials. To facilitate effective cell adhesion, migration, and deposition of endogenous extracellular matrix components by the cells, biomaterials for tissue engineering must have regulated surface chemistry, porosity, and biodegradability. To create a large cell mass that can perform certain differentiated roles required for the tissue build, strategies to switch cells between growth and differentiation, which are mutually exclusive, are applied. TE has a lot of potential. The social impact of TE will be extraordinary. It bears the promise of a long-term improvement in human life quality, as well as a decrease in the societal and economic costs of healthcare and life expectancy. It has the ability to provide early diagnosis of pathological disorders, lower the harshness of treatment, and improve the patient's clinical outcome. It could lead to the discovery of fresh methods for promoting health and lifespan.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States